2006
DOI: 10.1016/j.imlet.2006.03.004
|View full text |Cite
|
Sign up to set email alerts
|

The changing immunological paradigm in coeliac disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
43
0
3

Year Published

2007
2007
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 55 publications
(47 citation statements)
references
References 100 publications
1
43
0
3
Order By: Relevance
“…Two major findings were detected: a significant decrease in the numbers of circulating plasmablasts in CD and partly in DH, and an increased skinhoming potential of IgA1-plasmablasts compared with IgA2 cells in DH, but not in CD. Several studies have shown increased numbers of IgA-and IgG-containing cells in the intestinal mucosa of adult patients with CD [13][14][15][16][17] and IgA1 deposits in the skin of patients with DH [4,5,18]. For the first time, to our knowledge, the present study investigated the population of circulating plasmablasts, ISC, in adults with gluten enteropathy.…”
Section: Discussionmentioning
confidence: 97%
See 3 more Smart Citations
“…Two major findings were detected: a significant decrease in the numbers of circulating plasmablasts in CD and partly in DH, and an increased skinhoming potential of IgA1-plasmablasts compared with IgA2 cells in DH, but not in CD. Several studies have shown increased numbers of IgA-and IgG-containing cells in the intestinal mucosa of adult patients with CD [13][14][15][16][17] and IgA1 deposits in the skin of patients with DH [4,5,18]. For the first time, to our knowledge, the present study investigated the population of circulating plasmablasts, ISC, in adults with gluten enteropathy.…”
Section: Discussionmentioning
confidence: 97%
“…The decrease in circulating ISC in adults could imply an impairment of the local intestinal defence mechanisms leading to reduced induction of gut-directed ISC into the circulation. However, several earlier studies have shown increased numbers of IgA-, IgG-and IgM-plasma cells in the small bowel mucosa of untreated CD [15][16][17] and DH patients [17,43,44], accompanied by an increased production of these Igs from cultured mucosal biopsies [15]. After treatment, the mucosal plasma cell numbers have proved to decrease but not reach the levels of healthy individuals [15,16].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…1,2 The most accepted model of the CD immunopathogenesis is the two-signal model, which establishes that gliadin has a dual effect on the CD duodenum, triggering the development of an innate immune response in the epithelium, and activating an adaptive immune response controlled by gluten-reactive T cells with a Th1 cytokine profile. 3,4 Innate immunity, and specifically interleukin (IL)-15, 5,6 plays a key role in the development of CD through a DQ2-independent mechanism. 7 The induction of IL-15 seems to be involved in the initial stages of the disease leading to epithelial stress, increase tightjunction permeability, enterocyte apoptosis and dendritic cell (DC) activation, 5,6,8---12 facilitating the development of the secondary adaptive response.…”
Section: Introductionmentioning
confidence: 99%